Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013
Identifieur interne : 001944 ( Istex/Corpus ); précédent : 001943; suivant : 001945Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013
Auteurs : Lakshmi N. Yatham ; Sidney H. Kennedy ; Sagar V. Parikh ; Ayal Schaffer ; Serge Beaulieu ; Martin Alda ; Claire O Onovan ; Glenda Macqueen ; Roger S. Mcintyre ; Verinder Sharma ; Arun Ravindran ; L Trevor Young ; Roumen Milev ; David J. Bond ; Benicio N. Frey ; Benjamin I. Goldstein ; Beny Lafer ; Boris Birmaher ; Kyooseob Ha ; Willem A. Nolen ; Michael BerkSource :
- Bipolar Disorders [ 1398-5647 ] ; 2013-02.
English descriptors
- KwdEn :
Abstract
Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, O’Donovan C, MacQueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Milev R, Bond DJ, Frey BN, Goldstein BI, Lafer B, Birmaher B, Ha K, Nolen WA, Berk M.
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.
Bipolar Disord 2012: 00: 000–000. © 2012 John Wiley & Sons A/S.Published by Blackwell Publishing Ltd. The Canadian Network for Mood and Anxiety Treatments published guidelines for the management of bipolar disorder in 2005, with updates in 2007 and 2009. This third update, in conjunction with the International Society for Bipolar Disorders, reviews new evidence and is designed to be used in conjunction with the previous publications.The recommendations for the management of acute mania remain largely unchanged. Lithium, valproate, and several atypical antipsychotic agents continue to be first‐line treatments for acute mania. Monotherapy with asenapine, paliperidone extended release (ER), and divalproex ER, as well as adjunctive asenapine, have been added as first‐line options.For the management of bipolar depression, lithium, lamotrigine, and quetiapine monotherapy, as well as olanzapine plus selective serotonin reuptake inhibitor (SSRI), and lithium or divalproex plus SSRI/bupropion remain first‐line options. Lurasidone monotherapy and the combination of lurasidone or lamotrigine plus lithium or divalproex have been added as a second‐line options. Ziprasidone alone or as adjunctive therapy, and adjunctive levetiracetam have been added as not‐recommended options for the treatment of bipolar depression. Lithium, lamotrigine, valproate, olanzapine, quetiapine, aripiprazole, risperidone long‐acting injection, and adjunctive ziprasidone continue to be first‐line options for maintenance treatment of bipolar disorder. Asenapine alone or as adjunctive therapy have been added as third‐line options.
Url:
DOI: 10.1111/bdi.12025
Links to Exploration step
ISTEX:AD625393E9E58F51738C0841F0B5A4EA39BC1E11Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013</title><author><name sortKey="Yatham, Lakshmi N" sort="Yatham, Lakshmi N" uniqKey="Yatham L" first="Lakshmi N" last="Yatham">Lakshmi N. Yatham</name><affiliation><mods:affiliation>Department of Psychiatry, University of British Columbia, Vancouver, BC</mods:affiliation></affiliation></author><author><name sortKey="Kennedy, Sidney H" sort="Kennedy, Sidney H" uniqKey="Kennedy S" first="Sidney H" last="Kennedy">Sidney H. Kennedy</name><affiliation><mods:affiliation>Department of Psychiatry, University of Toronto, Toronto, ON</mods:affiliation></affiliation></author><author><name sortKey="Parikh, Sagar V" sort="Parikh, Sagar V" uniqKey="Parikh S" first="Sagar V" last="Parikh">Sagar V. Parikh</name><affiliation><mods:affiliation>Department of Psychiatry, University of Toronto, Toronto, ON</mods:affiliation></affiliation></author><author><name sortKey="Schaffer, Ayal" sort="Schaffer, Ayal" uniqKey="Schaffer A" first="Ayal" last="Schaffer">Ayal Schaffer</name><affiliation><mods:affiliation>Department of Psychiatry, University of Toronto, Toronto, ON</mods:affiliation></affiliation></author><author><name sortKey="Beaulieu, Serge" sort="Beaulieu, Serge" uniqKey="Beaulieu S" first="Serge" last="Beaulieu">Serge Beaulieu</name><affiliation><mods:affiliation>Department of Psychiatry, McGill University, Montreal, QC</mods:affiliation></affiliation></author><author><name sortKey="Alda, Martin" sort="Alda, Martin" uniqKey="Alda M" first="Martin" last="Alda">Martin Alda</name><affiliation><mods:affiliation>Department of Psychiatry, Dalhousie University, Halifax, NS</mods:affiliation></affiliation></author><author><name sortKey="O Onovan, Claire" sort="O Onovan, Claire" uniqKey="O Onovan C" first="Claire" last="O Onovan">Claire O Onovan</name><affiliation><mods:affiliation>Department of Psychiatry, Dalhousie University, Halifax, NS</mods:affiliation></affiliation></author><author><name sortKey="Macqueen, Glenda" sort="Macqueen, Glenda" uniqKey="Macqueen G" first="Glenda" last="Macqueen">Glenda Macqueen</name><affiliation><mods:affiliation>Department of Psychiatry, University of Calgary, Calgary, AB</mods:affiliation></affiliation></author><author><name sortKey="Mcintyre, Roger S" sort="Mcintyre, Roger S" uniqKey="Mcintyre R" first="Roger S" last="Mcintyre">Roger S. Mcintyre</name><affiliation><mods:affiliation>Department of Psychiatry, University of Toronto, Toronto, ON</mods:affiliation></affiliation></author><author><name sortKey="Sharma, Verinder" sort="Sharma, Verinder" uniqKey="Sharma V" first="Verinder" last="Sharma">Verinder Sharma</name><affiliation><mods:affiliation>Department of Psychiatry, University of Western Ontario, London, ON</mods:affiliation></affiliation></author><author><name sortKey="Ravindran, Arun" sort="Ravindran, Arun" uniqKey="Ravindran A" first="Arun" last="Ravindran">Arun Ravindran</name><affiliation><mods:affiliation>Department of Psychiatry, University of Toronto, Toronto, ON</mods:affiliation></affiliation></author><author><name sortKey="Young, L Trevor" sort="Young, L Trevor" uniqKey="Young L" first="L Trevor" last="Young">L Trevor Young</name><affiliation><mods:affiliation>Department of Psychiatry, University of British Columbia, Vancouver, BC</mods:affiliation></affiliation></author><author><name sortKey="Milev, Roumen" sort="Milev, Roumen" uniqKey="Milev R" first="Roumen" last="Milev">Roumen Milev</name><affiliation><mods:affiliation>Department of Psychiatry, Queen’s University, Kingston, ON</mods:affiliation></affiliation></author><author><name sortKey="Bond, David J" sort="Bond, David J" uniqKey="Bond D" first="David J" last="Bond">David J. Bond</name><affiliation><mods:affiliation>Department of Psychiatry, University of British Columbia, Vancouver, BC</mods:affiliation></affiliation></author><author><name sortKey="Frey, Benicio N" sort="Frey, Benicio N" uniqKey="Frey B" first="Benicio N" last="Frey">Benicio N. Frey</name><affiliation><mods:affiliation>Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON</mods:affiliation></affiliation></author><author><name sortKey="Goldstein, Benjamin I" sort="Goldstein, Benjamin I" uniqKey="Goldstein B" first="Benjamin I" last="Goldstein">Benjamin I. Goldstein</name><affiliation><mods:affiliation>Sunnybrook Health Sciences Centre, Toronto, ON, Canada</mods:affiliation></affiliation></author><author><name sortKey="Lafer, Beny" sort="Lafer, Beny" uniqKey="Lafer B" first="Beny" last="Lafer">Beny Lafer</name><affiliation><mods:affiliation>Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil</mods:affiliation></affiliation></author><author><name sortKey="Birmaher, Boris" sort="Birmaher, Boris" uniqKey="Birmaher B" first="Boris" last="Birmaher">Boris Birmaher</name><affiliation><mods:affiliation>Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh, Pittsburgh, PA, USA</mods:affiliation></affiliation></author><author><name sortKey="Ha, Kyooseob" sort="Ha, Kyooseob" uniqKey="Ha K" first="Kyooseob" last="Ha">Kyooseob Ha</name><affiliation><mods:affiliation>Department of Psychiatry, Seoul National University, Seoul, Korea</mods:affiliation></affiliation></author><author><name sortKey="Nolen, Willem A" sort="Nolen, Willem A" uniqKey="Nolen W" first="Willem A" last="Nolen">Willem A. Nolen</name><affiliation><mods:affiliation>Department of Psychiatry, University Medical Center, Groningen, The Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Berk, Michael" sort="Berk, Michael" uniqKey="Berk M" first="Michael" last="Berk">Michael Berk</name><affiliation><mods:affiliation>School of Medicine, Deakin University, Geelong</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Psychiatry, University of Melbourne, Parkville, Victoria, Australia</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:AD625393E9E58F51738C0841F0B5A4EA39BC1E11</idno><date when="2013" year="2013">2013</date><idno type="doi">10.1111/bdi.12025</idno><idno type="url">https://api.istex.fr/document/AD625393E9E58F51738C0841F0B5A4EA39BC1E11/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001944</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001944</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013</title><author><name sortKey="Yatham, Lakshmi N" sort="Yatham, Lakshmi N" uniqKey="Yatham L" first="Lakshmi N" last="Yatham">Lakshmi N. Yatham</name><affiliation><mods:affiliation>Department of Psychiatry, University of British Columbia, Vancouver, BC</mods:affiliation></affiliation></author><author><name sortKey="Kennedy, Sidney H" sort="Kennedy, Sidney H" uniqKey="Kennedy S" first="Sidney H" last="Kennedy">Sidney H. Kennedy</name><affiliation><mods:affiliation>Department of Psychiatry, University of Toronto, Toronto, ON</mods:affiliation></affiliation></author><author><name sortKey="Parikh, Sagar V" sort="Parikh, Sagar V" uniqKey="Parikh S" first="Sagar V" last="Parikh">Sagar V. Parikh</name><affiliation><mods:affiliation>Department of Psychiatry, University of Toronto, Toronto, ON</mods:affiliation></affiliation></author><author><name sortKey="Schaffer, Ayal" sort="Schaffer, Ayal" uniqKey="Schaffer A" first="Ayal" last="Schaffer">Ayal Schaffer</name><affiliation><mods:affiliation>Department of Psychiatry, University of Toronto, Toronto, ON</mods:affiliation></affiliation></author><author><name sortKey="Beaulieu, Serge" sort="Beaulieu, Serge" uniqKey="Beaulieu S" first="Serge" last="Beaulieu">Serge Beaulieu</name><affiliation><mods:affiliation>Department of Psychiatry, McGill University, Montreal, QC</mods:affiliation></affiliation></author><author><name sortKey="Alda, Martin" sort="Alda, Martin" uniqKey="Alda M" first="Martin" last="Alda">Martin Alda</name><affiliation><mods:affiliation>Department of Psychiatry, Dalhousie University, Halifax, NS</mods:affiliation></affiliation></author><author><name sortKey="O Onovan, Claire" sort="O Onovan, Claire" uniqKey="O Onovan C" first="Claire" last="O Onovan">Claire O Onovan</name><affiliation><mods:affiliation>Department of Psychiatry, Dalhousie University, Halifax, NS</mods:affiliation></affiliation></author><author><name sortKey="Macqueen, Glenda" sort="Macqueen, Glenda" uniqKey="Macqueen G" first="Glenda" last="Macqueen">Glenda Macqueen</name><affiliation><mods:affiliation>Department of Psychiatry, University of Calgary, Calgary, AB</mods:affiliation></affiliation></author><author><name sortKey="Mcintyre, Roger S" sort="Mcintyre, Roger S" uniqKey="Mcintyre R" first="Roger S" last="Mcintyre">Roger S. Mcintyre</name><affiliation><mods:affiliation>Department of Psychiatry, University of Toronto, Toronto, ON</mods:affiliation></affiliation></author><author><name sortKey="Sharma, Verinder" sort="Sharma, Verinder" uniqKey="Sharma V" first="Verinder" last="Sharma">Verinder Sharma</name><affiliation><mods:affiliation>Department of Psychiatry, University of Western Ontario, London, ON</mods:affiliation></affiliation></author><author><name sortKey="Ravindran, Arun" sort="Ravindran, Arun" uniqKey="Ravindran A" first="Arun" last="Ravindran">Arun Ravindran</name><affiliation><mods:affiliation>Department of Psychiatry, University of Toronto, Toronto, ON</mods:affiliation></affiliation></author><author><name sortKey="Young, L Trevor" sort="Young, L Trevor" uniqKey="Young L" first="L Trevor" last="Young">L Trevor Young</name><affiliation><mods:affiliation>Department of Psychiatry, University of British Columbia, Vancouver, BC</mods:affiliation></affiliation></author><author><name sortKey="Milev, Roumen" sort="Milev, Roumen" uniqKey="Milev R" first="Roumen" last="Milev">Roumen Milev</name><affiliation><mods:affiliation>Department of Psychiatry, Queen’s University, Kingston, ON</mods:affiliation></affiliation></author><author><name sortKey="Bond, David J" sort="Bond, David J" uniqKey="Bond D" first="David J" last="Bond">David J. Bond</name><affiliation><mods:affiliation>Department of Psychiatry, University of British Columbia, Vancouver, BC</mods:affiliation></affiliation></author><author><name sortKey="Frey, Benicio N" sort="Frey, Benicio N" uniqKey="Frey B" first="Benicio N" last="Frey">Benicio N. Frey</name><affiliation><mods:affiliation>Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON</mods:affiliation></affiliation></author><author><name sortKey="Goldstein, Benjamin I" sort="Goldstein, Benjamin I" uniqKey="Goldstein B" first="Benjamin I" last="Goldstein">Benjamin I. Goldstein</name><affiliation><mods:affiliation>Sunnybrook Health Sciences Centre, Toronto, ON, Canada</mods:affiliation></affiliation></author><author><name sortKey="Lafer, Beny" sort="Lafer, Beny" uniqKey="Lafer B" first="Beny" last="Lafer">Beny Lafer</name><affiliation><mods:affiliation>Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil</mods:affiliation></affiliation></author><author><name sortKey="Birmaher, Boris" sort="Birmaher, Boris" uniqKey="Birmaher B" first="Boris" last="Birmaher">Boris Birmaher</name><affiliation><mods:affiliation>Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh, Pittsburgh, PA, USA</mods:affiliation></affiliation></author><author><name sortKey="Ha, Kyooseob" sort="Ha, Kyooseob" uniqKey="Ha K" first="Kyooseob" last="Ha">Kyooseob Ha</name><affiliation><mods:affiliation>Department of Psychiatry, Seoul National University, Seoul, Korea</mods:affiliation></affiliation></author><author><name sortKey="Nolen, Willem A" sort="Nolen, Willem A" uniqKey="Nolen W" first="Willem A" last="Nolen">Willem A. Nolen</name><affiliation><mods:affiliation>Department of Psychiatry, University Medical Center, Groningen, The Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Berk, Michael" sort="Berk, Michael" uniqKey="Berk M" first="Michael" last="Berk">Michael Berk</name><affiliation><mods:affiliation>School of Medicine, Deakin University, Geelong</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Psychiatry, University of Melbourne, Parkville, Victoria, Australia</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Bipolar Disorders</title><idno type="ISSN">1398-5647</idno><idno type="eISSN">1399-5618</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2013-02">2013-02</date><biblScope unit="volume">15</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="1">1</biblScope><biblScope unit="page" to="44">44</biblScope></imprint><idno type="ISSN">1398-5647</idno></series><idno type="istex">AD625393E9E58F51738C0841F0B5A4EA39BC1E11</idno><idno type="DOI">10.1111/bdi.12025</idno><idno type="ArticleID">BDI12025</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1398-5647</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>CANMAT</term><term>bipolar</term><term>depression</term><term>guidelines</term><term>mania</term><term>treatment</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, O’Donovan C, MacQueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Milev R, Bond DJ, Frey BN, Goldstein BI, Lafer B, Birmaher B, Ha K, Nolen WA, Berk M.
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.
Bipolar Disord 2012: 00: 000–000. © 2012 John Wiley & Sons A/S.Published by Blackwell Publishing Ltd. The Canadian Network for Mood and Anxiety Treatments published guidelines for the management of bipolar disorder in 2005, with updates in 2007 and 2009. This third update, in conjunction with the International Society for Bipolar Disorders, reviews new evidence and is designed to be used in conjunction with the previous publications.The recommendations for the management of acute mania remain largely unchanged. Lithium, valproate, and several atypical antipsychotic agents continue to be first‐line treatments for acute mania. Monotherapy with asenapine, paliperidone extended release (ER), and divalproex ER, as well as adjunctive asenapine, have been added as first‐line options.For the management of bipolar depression, lithium, lamotrigine, and quetiapine monotherapy, as well as olanzapine plus selective serotonin reuptake inhibitor (SSRI), and lithium or divalproex plus SSRI/bupropion remain first‐line options. Lurasidone monotherapy and the combination of lurasidone or lamotrigine plus lithium or divalproex have been added as a second‐line options. Ziprasidone alone or as adjunctive therapy, and adjunctive levetiracetam have been added as not‐recommended options for the treatment of bipolar depression. Lithium, lamotrigine, valproate, olanzapine, quetiapine, aripiprazole, risperidone long‐acting injection, and adjunctive ziprasidone continue to be first‐line options for maintenance treatment of bipolar disorder. Asenapine alone or as adjunctive therapy have been added as third‐line options.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Lakshmi N Yatham</name><affiliations><json:string>Department of Psychiatry, University of British Columbia, Vancouver, BC</json:string></affiliations></json:item><json:item><name>Sidney H Kennedy</name><affiliations><json:string>Department of Psychiatry, University of Toronto, Toronto, ON</json:string></affiliations></json:item><json:item><name>Sagar V Parikh</name><affiliations><json:string>Department of Psychiatry, University of Toronto, Toronto, ON</json:string></affiliations></json:item><json:item><name>Ayal Schaffer</name><affiliations><json:string>Department of Psychiatry, University of Toronto, Toronto, ON</json:string></affiliations></json:item><json:item><name>Serge Beaulieu</name><affiliations><json:string>Department of Psychiatry, McGill University, Montreal, QC</json:string></affiliations></json:item><json:item><name>Martin Alda</name><affiliations><json:string>Department of Psychiatry, Dalhousie University, Halifax, NS</json:string></affiliations></json:item><json:item><name>Claire O’Donovan</name><affiliations><json:string>Department of Psychiatry, Dalhousie University, Halifax, NS</json:string></affiliations></json:item><json:item><name>Glenda MacQueen</name><affiliations><json:string>Department of Psychiatry, University of Calgary, Calgary, AB</json:string></affiliations></json:item><json:item><name>Roger S McIntyre</name><affiliations><json:string>Department of Psychiatry, University of Toronto, Toronto, ON</json:string></affiliations></json:item><json:item><name>Verinder Sharma</name><affiliations><json:string>Department of Psychiatry, University of Western Ontario, London, ON</json:string></affiliations></json:item><json:item><name>Arun Ravindran</name><affiliations><json:string>Department of Psychiatry, University of Toronto, Toronto, ON</json:string></affiliations></json:item><json:item><name>L Trevor Young</name><affiliations><json:string>Department of Psychiatry, University of British Columbia, Vancouver, BC</json:string></affiliations></json:item><json:item><name>Roumen Milev</name><affiliations><json:string>Department of Psychiatry, Queen’s University, Kingston, ON</json:string></affiliations></json:item><json:item><name>David J Bond</name><affiliations><json:string>Department of Psychiatry, University of British Columbia, Vancouver, BC</json:string></affiliations></json:item><json:item><name>Benicio N Frey</name><affiliations><json:string>Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON</json:string></affiliations></json:item><json:item><name>Benjamin I Goldstein</name><affiliations><json:string>Sunnybrook Health Sciences Centre, Toronto, ON, Canada</json:string></affiliations></json:item><json:item><name>Beny Lafer</name><affiliations><json:string>Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil</json:string></affiliations></json:item><json:item><name>Boris Birmaher</name><affiliations><json:string>Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh, Pittsburgh, PA, USA</json:string></affiliations></json:item><json:item><name>Kyooseob Ha</name><affiliations><json:string>Department of Psychiatry, Seoul National University, Seoul, Korea</json:string></affiliations></json:item><json:item><name>Willem A Nolen</name><affiliations><json:string>Department of Psychiatry, University Medical Center, Groningen, The Netherlands</json:string></affiliations></json:item><json:item><name>Michael Berk</name><affiliations><json:string>School of Medicine, Deakin University, Geelong</json:string><json:string>Department of Psychiatry, University of Melbourne, Parkville, Victoria, Australia</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>bipolar</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>CANMAT</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>depression</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>guidelines</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>mania</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>treatment</value></json:item></subject><articleId><json:string>BDI12025</json:string></articleId><language><json:string>eng</json:string></language><originalGenre><json:string>article</json:string></originalGenre><abstract>Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, O’Donovan C, MacQueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Milev R, Bond DJ, Frey BN, Goldstein BI, Lafer B, Birmaher B, Ha K, Nolen WA, Berk M. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord 2012: 00: 000–000. © 2012 John Wiley & Sons A/S.Published by Blackwell Publishing Ltd. The Canadian Network for Mood and Anxiety Treatments published guidelines for the management of bipolar disorder in 2005, with updates in 2007 and 2009. This third update, in conjunction with the International Society for Bipolar Disorders, reviews new evidence and is designed to be used in conjunction with the previous publications.The recommendations for the management of acute mania remain largely unchanged. Lithium, valproate, and several atypical antipsychotic agents continue to be first‐line treatments for acute mania. Monotherapy with asenapine, paliperidone extended release (ER), and divalproex ER, as well as adjunctive asenapine, have been added as first‐line options.For the management of bipolar depression, lithium, lamotrigine, and quetiapine monotherapy, as well as olanzapine plus selective serotonin reuptake inhibitor (SSRI), and lithium or divalproex plus SSRI/bupropion remain first‐line options. Lurasidone monotherapy and the combination of lurasidone or lamotrigine plus lithium or divalproex have been added as a second‐line options. Ziprasidone alone or as adjunctive therapy, and adjunctive levetiracetam have been added as not‐recommended options for the treatment of bipolar depression. Lithium, lamotrigine, valproate, olanzapine, quetiapine, aripiprazole, risperidone long‐acting injection, and adjunctive ziprasidone continue to be first‐line options for maintenance treatment of bipolar disorder. Asenapine alone or as adjunctive therapy have been added as third‐line options.</abstract><qualityIndicators><score>8</score><pdfVersion>1.3</pdfVersion><pdfPageSize>595.276 x 799.37 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>2064</abstractCharCount><pdfWordCount>29366</pdfWordCount><pdfCharCount>194128</pdfCharCount><pdfPageCount>44</pdfPageCount><abstractWordCount>290</abstractWordCount></qualityIndicators><title>Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013</title><genre><json:string>article</json:string></genre><host><volume>15</volume><publisherId><json:string>BDI</json:string></publisherId><pages><total>44</total><last>44</last><first>1</first></pages><issn><json:string>1398-5647</json:string></issn><issue>1</issue><subject><json:item><value>Guidelines Update</value></json:item></subject><genre><json:string>journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1399-5618</json:string></eissn><title>Bipolar Disorders</title><doi><json:string>10.1111/(ISSN)1399-5618</json:string></doi></host><categories><wos><json:string>social science</json:string><json:string>psychiatry</json:string><json:string>science</json:string><json:string>neurosciences</json:string><json:string>clinical neurology</json:string></wos><scienceMetrix><json:string>health sciences</json:string><json:string>clinical medicine</json:string><json:string>psychiatry</json:string></scienceMetrix><inist><json:string>sciences humaines et sociales</json:string></inist></categories><publicationDate>2013</publicationDate><copyrightDate>2013</copyrightDate><doi><json:string>10.1111/bdi.12025</json:string></doi><id>AD625393E9E58F51738C0841F0B5A4EA39BC1E11</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/document/AD625393E9E58F51738C0841F0B5A4EA39BC1E11/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/document/AD625393E9E58F51738C0841F0B5A4EA39BC1E11/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/AD625393E9E58F51738C0841F0B5A4EA39BC1E11/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><availability><p>© 2012 John Wiley and Sons A/S</p></availability><date>2013</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013</title><author xml:id="author-1"><persName><forename type="first">Lakshmi N</forename><surname>Yatham</surname></persName><affiliation>Department of Psychiatry, University of British Columbia, Vancouver, BC</affiliation></author><author xml:id="author-2"><persName><forename type="first">Sidney H</forename><surname>Kennedy</surname></persName><affiliation>Department of Psychiatry, University of Toronto, Toronto, ON</affiliation></author><author xml:id="author-3"><persName><forename type="first">Sagar V</forename><surname>Parikh</surname></persName><affiliation>Department of Psychiatry, University of Toronto, Toronto, ON</affiliation></author><author xml:id="author-4"><persName><forename type="first">Ayal</forename><surname>Schaffer</surname></persName><affiliation>Department of Psychiatry, University of Toronto, Toronto, ON</affiliation></author><author xml:id="author-5"><persName><forename type="first">Serge</forename><surname>Beaulieu</surname></persName><affiliation>Department of Psychiatry, McGill University, Montreal, QC</affiliation></author><author xml:id="author-6"><persName><forename type="first">Martin</forename><surname>Alda</surname></persName><affiliation>Department of Psychiatry, Dalhousie University, Halifax, NS</affiliation></author><author xml:id="author-7"><persName><forename type="first">Claire</forename><surname>O’Donovan</surname></persName><affiliation>Department of Psychiatry, Dalhousie University, Halifax, NS</affiliation></author><author xml:id="author-8"><persName><forename type="first">Glenda</forename><surname>MacQueen</surname></persName><affiliation>Department of Psychiatry, University of Calgary, Calgary, AB</affiliation></author><author xml:id="author-9"><persName><forename type="first">Roger S</forename><surname>McIntyre</surname></persName><affiliation>Department of Psychiatry, University of Toronto, Toronto, ON</affiliation></author><author xml:id="author-10"><persName><forename type="first">Verinder</forename><surname>Sharma</surname></persName><affiliation>Department of Psychiatry, University of Western Ontario, London, ON</affiliation></author><author xml:id="author-11"><persName><forename type="first">Arun</forename><surname>Ravindran</surname></persName><affiliation>Department of Psychiatry, University of Toronto, Toronto, ON</affiliation></author><author xml:id="author-12"><persName><forename type="first">L Trevor</forename><surname>Young</surname></persName><affiliation>Department of Psychiatry, University of British Columbia, Vancouver, BC</affiliation></author><author xml:id="author-13"><persName><forename type="first">Roumen</forename><surname>Milev</surname></persName><affiliation>Department of Psychiatry, Queen’s University, Kingston, ON</affiliation></author><author xml:id="author-14"><persName><forename type="first">David J</forename><surname>Bond</surname></persName><affiliation>Department of Psychiatry, University of British Columbia, Vancouver, BC</affiliation></author><author xml:id="author-15"><persName><forename type="first">Benicio N</forename><surname>Frey</surname></persName><affiliation>Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON</affiliation></author><author xml:id="author-16"><persName><forename type="first">Benjamin I</forename><surname>Goldstein</surname></persName><affiliation>Sunnybrook Health Sciences Centre, Toronto, ON, Canada</affiliation></author><author xml:id="author-17"><persName><forename type="first">Beny</forename><surname>Lafer</surname></persName><affiliation>Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil</affiliation></author><author xml:id="author-18"><persName><forename type="first">Boris</forename><surname>Birmaher</surname></persName><affiliation>Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh, Pittsburgh, PA, USA</affiliation></author><author xml:id="author-19"><persName><forename type="first">Kyooseob</forename><surname>Ha</surname></persName><affiliation>Department of Psychiatry, Seoul National University, Seoul, Korea</affiliation></author><author xml:id="author-20"><persName><forename type="first">Willem A</forename><surname>Nolen</surname></persName><affiliation>Department of Psychiatry, University Medical Center, Groningen, The Netherlands</affiliation></author><author xml:id="author-21"><persName><forename type="first">Michael</forename><surname>Berk</surname></persName><affiliation>School of Medicine, Deakin University, Geelong</affiliation><affiliation>Department of Psychiatry, University of Melbourne, Parkville, Victoria, Australia</affiliation></author></analytic><monogr><title level="j">Bipolar Disorders</title><idno type="pISSN">1398-5647</idno><idno type="eISSN">1399-5618</idno><idno type="DOI">10.1111/(ISSN)1399-5618</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2013-02"></date><biblScope unit="volume">15</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="1">1</biblScope><biblScope unit="page" to="44">44</biblScope></imprint></monogr><idno type="istex">AD625393E9E58F51738C0841F0B5A4EA39BC1E11</idno><idno type="DOI">10.1111/bdi.12025</idno><idno type="ArticleID">BDI12025</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2013</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, O’Donovan C, MacQueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Milev R, Bond DJ, Frey BN, Goldstein BI, Lafer B, Birmaher B, Ha K, Nolen WA, Berk M.
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.
Bipolar Disord 2012: 00: 000–000. © 2012 John Wiley & Sons A/S.Published by Blackwell Publishing Ltd. The Canadian Network for Mood and Anxiety Treatments published guidelines for the management of bipolar disorder in 2005, with updates in 2007 and 2009. This third update, in conjunction with the International Society for Bipolar Disorders, reviews new evidence and is designed to be used in conjunction with the previous publications.The recommendations for the management of acute mania remain largely unchanged. Lithium, valproate, and several atypical antipsychotic agents continue to be first‐line treatments for acute mania. Monotherapy with asenapine, paliperidone extended release (ER), and divalproex ER, as well as adjunctive asenapine, have been added as first‐line options.For the management of bipolar depression, lithium, lamotrigine, and quetiapine monotherapy, as well as olanzapine plus selective serotonin reuptake inhibitor (SSRI), and lithium or divalproex plus SSRI/bupropion remain first‐line options. Lurasidone monotherapy and the combination of lurasidone or lamotrigine plus lithium or divalproex have been added as a second‐line options. Ziprasidone alone or as adjunctive therapy, and adjunctive levetiracetam have been added as not‐recommended options for the treatment of bipolar depression. Lithium, lamotrigine, valproate, olanzapine, quetiapine, aripiprazole, risperidone long‐acting injection, and adjunctive ziprasidone continue to be first‐line options for maintenance treatment of bipolar disorder. Asenapine alone or as adjunctive therapy have been added as third‐line options.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>keywords</head><item><term>bipolar</term></item><item><term>CANMAT</term></item><item><term>depression</term></item><item><term>guidelines</term></item><item><term>mania</term></item><item><term>treatment</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>article-category</head><item><term>Guidelines Update</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2013-02">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/document/AD625393E9E58F51738C0841F0B5A4EA39BC1E11/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Blackwell Publishing Ltd</publisherName><publisherLoc>Oxford, UK</publisherLoc></publisherInfo><doi origin="wiley" registered="yes">10.1111/(ISSN)1399-5618</doi><issn type="print">1398-5647</issn><issn type="electronic">1399-5618</issn><idGroup><id type="product" value="BDI"></id><id type="publisherDivision" value="ST"></id></idGroup><titleGroup><title type="main" sort="BIPOLAR DISORDERS">Bipolar Disorders</title></titleGroup></publicationMeta><publicationMeta level="part" position="02101"><doi origin="wiley">10.1111/bdi.2013.15.issue-1</doi><numberingGroup><numbering type="journalVolume" number="15">15</numbering><numbering type="journalIssue" number="1">1</numbering></numberingGroup><coverDate startDate="2013-02">February 2013</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="1" status="forIssue"><doi origin="wiley">10.1111/bdi.12025</doi><idGroup><id type="unit" value="BDI12025"></id></idGroup><countGroup><count type="pageTotal" number="44"></count></countGroup><titleGroup><title type="tocHeading1">Guidelines Update</title><title type="articleCategory">Guidelines Update</title></titleGroup><copyright>© 2012 John Wiley and Sons A/S</copyright><eventGroup><event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:3.1.9 mode:FullText" date="2013-01-21"></event><event type="publishedOnlineEarlyUnpaginated" date="2012-12-12"></event><event type="firstOnline" date="2012-12-12"></event><event type="publishedOnlineFinalForm" date="2013-01-22"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-01-25"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.6.4 mode:FullText" date="2015-10-03"></event></eventGroup><numberingGroup><numbering type="pageFirst" number="1">1</numbering><numbering type="pageLast" number="44">44</numbering></numberingGroup><correspondenceTo>Corresponding author:
Lakshmi N. Yatham, MBBS, FRCPC, MRCPsych (UK)
Department of Psychiatry
University of British Columbia
2255 Wesbrook Mall
Vancouver, BC V6T 2A1
Canada
Fax: 604‐822‐7922
E‐mail: <email>yatham@interchange.ubc.ca</email></correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:BDI.BDI12025.pdf"></link></linkGroup></publicationMeta><contentMeta><unparsedEditorialHistory>Received 1 April 2012, revised and accepted for publication 30 September 2012</unparsedEditorialHistory><countGroup><count type="figureTotal" number="2"></count><count type="tableTotal" number="9"></count></countGroup><titleGroup><title type="main">Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013</title><title type="shortAuthors"><b>Yatham et al.</b></title><title type="short"><b>CANMAT guidelines for bipolar disorder</b></title></titleGroup><creators><creator creatorRole="author" xml:id="cr1" affiliationRef="#a1"><personName><givenNames>Lakshmi N</givenNames><familyName>Yatham</familyName></personName></creator><creator creatorRole="author" xml:id="cr2" affiliationRef="#a2"><personName><givenNames>Sidney H</givenNames><familyName>Kennedy</familyName></personName></creator><creator creatorRole="author" xml:id="cr3" affiliationRef="#a2"><personName><givenNames>Sagar V</givenNames><familyName>Parikh</familyName></personName></creator><creator creatorRole="author" xml:id="cr4" affiliationRef="#a2"><personName><givenNames>Ayal</givenNames><familyName>Schaffer</familyName></personName></creator><creator creatorRole="author" xml:id="cr5" affiliationRef="#a3"><personName><givenNames>Serge</givenNames><familyName>Beaulieu</familyName></personName></creator><creator creatorRole="author" xml:id="cr6" affiliationRef="#a4"><personName><givenNames>Martin</givenNames><familyName>Alda</familyName></personName></creator><creator creatorRole="author" xml:id="cr7" affiliationRef="#a4"><personName><givenNames>Claire</givenNames><familyName>O’Donovan</familyName></personName></creator><creator creatorRole="author" xml:id="cr8" affiliationRef="#a5"><personName><givenNames>Glenda</givenNames><familyName>MacQueen</familyName></personName></creator><creator creatorRole="author" xml:id="cr9" affiliationRef="#a2"><personName><givenNames>Roger S</givenNames><familyName>McIntyre</familyName></personName></creator><creator creatorRole="author" xml:id="cr10" affiliationRef="#a6"><personName><givenNames>Verinder</givenNames><familyName>Sharma</familyName></personName></creator><creator creatorRole="author" xml:id="cr11" affiliationRef="#a2"><personName><givenNames>Arun</givenNames><familyName>Ravindran</familyName></personName></creator><creator creatorRole="author" xml:id="cr12" affiliationRef="#a1"><personName><givenNames>L Trevor</givenNames><familyName>Young</familyName></personName></creator><creator creatorRole="author" xml:id="cr13" affiliationRef="#a7"><personName><givenNames>Roumen</givenNames><familyName>Milev</familyName></personName></creator><creator creatorRole="author" xml:id="cr14" affiliationRef="#a1"><personName><givenNames>David J</givenNames><familyName>Bond</familyName></personName></creator><creator creatorRole="author" xml:id="cr15" affiliationRef="#a8"><personName><givenNames>Benicio N</givenNames><familyName>Frey</familyName></personName></creator><creator creatorRole="author" xml:id="cr16" affiliationRef="#a9"><personName><givenNames>Benjamin I</givenNames><familyName>Goldstein</familyName></personName></creator><creator creatorRole="author" xml:id="cr17" affiliationRef="#a10"><personName><givenNames>Beny</givenNames><familyName>Lafer</familyName></personName></creator><creator creatorRole="author" xml:id="cr18" affiliationRef="#a11"><personName><givenNames>Boris</givenNames><familyName>Birmaher</familyName></personName></creator><creator creatorRole="author" xml:id="cr19" affiliationRef="#a12"><personName><givenNames>Kyooseob</givenNames><familyName>Ha</familyName></personName></creator><creator creatorRole="author" xml:id="cr20" affiliationRef="#a13"><personName><givenNames>Willem A</givenNames><familyName>Nolen</familyName></personName></creator><creator creatorRole="author" xml:id="cr21" affiliationRef="#a14 #a15"><personName><givenNames>Michael</givenNames><familyName>Berk</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="a1"><unparsedAffiliation>Department of Psychiatry, University of British Columbia, Vancouver, BC</unparsedAffiliation></affiliation><affiliation xml:id="a2"><unparsedAffiliation>Department of Psychiatry, University of Toronto, Toronto, ON</unparsedAffiliation></affiliation><affiliation xml:id="a3"><unparsedAffiliation>Department of Psychiatry, McGill University, Montreal, QC</unparsedAffiliation></affiliation><affiliation xml:id="a4"><unparsedAffiliation>Department of Psychiatry, Dalhousie University, Halifax, NS</unparsedAffiliation></affiliation><affiliation xml:id="a5"><unparsedAffiliation>Department of Psychiatry, University of Calgary, Calgary, AB</unparsedAffiliation></affiliation><affiliation xml:id="a6"><unparsedAffiliation>Department of Psychiatry, University of Western Ontario, London, ON</unparsedAffiliation></affiliation><affiliation xml:id="a7"><unparsedAffiliation>Department of Psychiatry, Queen’s University, Kingston, ON</unparsedAffiliation></affiliation><affiliation xml:id="a8"><unparsedAffiliation>Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON</unparsedAffiliation></affiliation><affiliation xml:id="a9" countryCode="CA"><unparsedAffiliation>Sunnybrook Health Sciences Centre, Toronto, ON, Canada</unparsedAffiliation></affiliation><affiliation xml:id="a10" countryCode="BR"><unparsedAffiliation>Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil</unparsedAffiliation></affiliation><affiliation xml:id="a11" countryCode="US"><unparsedAffiliation>Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh, Pittsburgh, PA, USA</unparsedAffiliation></affiliation><affiliation xml:id="a12" countryCode="KR"><unparsedAffiliation>Department of Psychiatry, Seoul National University, Seoul, Korea</unparsedAffiliation></affiliation><affiliation xml:id="a13" countryCode="NL"><unparsedAffiliation>Department of Psychiatry, University Medical Center, Groningen, The Netherlands</unparsedAffiliation></affiliation><affiliation xml:id="a14"><unparsedAffiliation>School of Medicine, Deakin University, Geelong</unparsedAffiliation></affiliation><affiliation xml:id="a15" countryCode="AU"><unparsedAffiliation>Department of Psychiatry, University of Melbourne, Parkville, Victoria, Australia</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en"><keyword xml:id="k1">bipolar</keyword><keyword xml:id="k2">CANMAT</keyword><keyword xml:id="k3">depression</keyword><keyword xml:id="k4">guidelines</keyword><keyword xml:id="k5">mania</keyword><keyword xml:id="k6">treatment</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><p>Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, O’Donovan C, MacQueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Milev R, Bond DJ, Frey BN, Goldstein BI, Lafer B, Birmaher B, Ha K, Nolen WA, Berk M.
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.
Bipolar Disord 2012: 00: 000–000. © 2012 John Wiley & Sons A/S.Published by Blackwell Publishing Ltd.</p><p>The Canadian Network for Mood and Anxiety Treatments published guidelines for the management of bipolar disorder in 2005, with updates in 2007 and 2009. This third update, in conjunction with the International Society for Bipolar Disorders, reviews new evidence and is designed to be used in conjunction with the previous publications.The recommendations for the management of acute mania remain largely unchanged. Lithium, valproate, and several atypical antipsychotic agents continue to be first‐line treatments for acute mania. Monotherapy with asenapine, paliperidone extended release (ER), and divalproex ER, as well as adjunctive asenapine, have been added as first‐line options.For the management of bipolar depression, lithium, lamotrigine, and quetiapine monotherapy, as well as olanzapine plus selective serotonin reuptake inhibitor (SSRI), and lithium or divalproex plus SSRI/bupropion remain first‐line options. Lurasidone monotherapy and the combination of lurasidone or lamotrigine plus lithium or divalproex have been added as a second‐line options. Ziprasidone alone or as adjunctive therapy, and adjunctive levetiracetam have been added as not‐recommended options for the treatment of bipolar depression. Lithium, lamotrigine, valproate, olanzapine, quetiapine, aripiprazole, risperidone long‐acting injection, and adjunctive ziprasidone continue to be first‐line options for maintenance treatment of bipolar disorder. Asenapine alone or as adjunctive therapy have been added as third‐line options.</p></abstract></abstractGroup></contentMeta><noteGroup><note xml:id="fn1"><p>Affililations for all authors are listed before the references.</p></note></noteGroup></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>CANMAT guidelines for bipolar disorder</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013</title></titleInfo><name type="personal"><namePart type="given">Lakshmi N</namePart><namePart type="family">Yatham</namePart><affiliation>Department of Psychiatry, University of British Columbia, Vancouver, BC</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Sidney H</namePart><namePart type="family">Kennedy</namePart><affiliation>Department of Psychiatry, University of Toronto, Toronto, ON</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Sagar V</namePart><namePart type="family">Parikh</namePart><affiliation>Department of Psychiatry, University of Toronto, Toronto, ON</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Ayal</namePart><namePart type="family">Schaffer</namePart><affiliation>Department of Psychiatry, University of Toronto, Toronto, ON</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Serge</namePart><namePart type="family">Beaulieu</namePart><affiliation>Department of Psychiatry, McGill University, Montreal, QC</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Martin</namePart><namePart type="family">Alda</namePart><affiliation>Department of Psychiatry, Dalhousie University, Halifax, NS</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Claire</namePart><namePart type="family">O’Donovan</namePart><affiliation>Department of Psychiatry, Dalhousie University, Halifax, NS</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Glenda</namePart><namePart type="family">MacQueen</namePart><affiliation>Department of Psychiatry, University of Calgary, Calgary, AB</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Roger S</namePart><namePart type="family">McIntyre</namePart><affiliation>Department of Psychiatry, University of Toronto, Toronto, ON</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Verinder</namePart><namePart type="family">Sharma</namePart><affiliation>Department of Psychiatry, University of Western Ontario, London, ON</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Arun</namePart><namePart type="family">Ravindran</namePart><affiliation>Department of Psychiatry, University of Toronto, Toronto, ON</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L Trevor</namePart><namePart type="family">Young</namePart><affiliation>Department of Psychiatry, University of British Columbia, Vancouver, BC</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Roumen</namePart><namePart type="family">Milev</namePart><affiliation>Department of Psychiatry, Queen’s University, Kingston, ON</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">David J</namePart><namePart type="family">Bond</namePart><affiliation>Department of Psychiatry, University of British Columbia, Vancouver, BC</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Benicio N</namePart><namePart type="family">Frey</namePart><affiliation>Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Benjamin I</namePart><namePart type="family">Goldstein</namePart><affiliation>Sunnybrook Health Sciences Centre, Toronto, ON, Canada</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Beny</namePart><namePart type="family">Lafer</namePart><affiliation>Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Boris</namePart><namePart type="family">Birmaher</namePart><affiliation>Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh, Pittsburgh, PA, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Kyooseob</namePart><namePart type="family">Ha</namePart><affiliation>Department of Psychiatry, Seoul National University, Seoul, Korea</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Willem A</namePart><namePart type="family">Nolen</namePart><affiliation>Department of Psychiatry, University Medical Center, Groningen, The Netherlands</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Michael</namePart><namePart type="family">Berk</namePart><affiliation>School of Medicine, Deakin University, Geelong</affiliation><affiliation>Department of Psychiatry, University of Melbourne, Parkville, Victoria, Australia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article"></genre><originInfo><publisher>Blackwell Publishing Ltd</publisher><place><placeTerm type="text">Oxford, UK</placeTerm></place><dateIssued encoding="w3cdtf">2013-02</dateIssued><edition>Received 1 April 2012, revised and accepted for publication 30 September 2012</edition><copyrightDate encoding="w3cdtf">2013</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="figures">2</extent><extent unit="tables">9</extent></physicalDescription><abstract lang="en">Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, O’Donovan C, MacQueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Milev R, Bond DJ, Frey BN, Goldstein BI, Lafer B, Birmaher B, Ha K, Nolen WA, Berk M.
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.
Bipolar Disord 2012: 00: 000–000. © 2012 John Wiley & Sons A/S.Published by Blackwell Publishing Ltd. The Canadian Network for Mood and Anxiety Treatments published guidelines for the management of bipolar disorder in 2005, with updates in 2007 and 2009. This third update, in conjunction with the International Society for Bipolar Disorders, reviews new evidence and is designed to be used in conjunction with the previous publications.The recommendations for the management of acute mania remain largely unchanged. Lithium, valproate, and several atypical antipsychotic agents continue to be first‐line treatments for acute mania. Monotherapy with asenapine, paliperidone extended release (ER), and divalproex ER, as well as adjunctive asenapine, have been added as first‐line options.For the management of bipolar depression, lithium, lamotrigine, and quetiapine monotherapy, as well as olanzapine plus selective serotonin reuptake inhibitor (SSRI), and lithium or divalproex plus SSRI/bupropion remain first‐line options. Lurasidone monotherapy and the combination of lurasidone or lamotrigine plus lithium or divalproex have been added as a second‐line options. Ziprasidone alone or as adjunctive therapy, and adjunctive levetiracetam have been added as not‐recommended options for the treatment of bipolar depression. Lithium, lamotrigine, valproate, olanzapine, quetiapine, aripiprazole, risperidone long‐acting injection, and adjunctive ziprasidone continue to be first‐line options for maintenance treatment of bipolar disorder. Asenapine alone or as adjunctive therapy have been added as third‐line options.</abstract><subject lang="en"><genre>keywords</genre><topic>bipolar</topic><topic>CANMAT</topic><topic>depression</topic><topic>guidelines</topic><topic>mania</topic><topic>treatment</topic></subject><relatedItem type="host"><titleInfo><title>Bipolar Disorders</title></titleInfo><genre type="journal">journal</genre><subject><genre>article-category</genre><topic>Guidelines Update</topic></subject><identifier type="ISSN">1398-5647</identifier><identifier type="eISSN">1399-5618</identifier><identifier type="DOI">10.1111/(ISSN)1399-5618</identifier><identifier type="PublisherID">BDI</identifier><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><detail type="issue"><caption>no.</caption><number>1</number></detail><extent unit="pages"><start>1</start><end>44</end><total>44</total></extent></part></relatedItem><identifier type="istex">AD625393E9E58F51738C0841F0B5A4EA39BC1E11</identifier><identifier type="DOI">10.1111/bdi.12025</identifier><identifier type="ArticleID">BDI12025</identifier><accessCondition type="use and reproduction" contentType="copyright">© 2012 John Wiley and Sons A/S</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Blackwell Publishing Ltd</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Psychologie/explor/TherFamFrancoV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001944 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001944 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Psychologie
|area= TherFamFrancoV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:AD625393E9E58F51738C0841F0B5A4EA39BC1E11
|texte= Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013
}}
| This area was generated with Dilib version V0.6.29. |  |